$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
[Usage and Dosage] How much lorlatinib should be taken per day? How long does it take to be effective
2025-10-19 11:44:20
Check Details
Can lorlatinib be purchased in Henan? Can it be reimbursed by medical insurance
2025-10-19 11:44:20
Check Details
How many aletinib pills a day? What should I pay attention to while taking alectinib?
2025-10-19 11:44:20
Check Details
What are the 8 early signs of lung cancer? How effective is alectinib treatment?
2025-10-19 11:44:20
Check Details
Who can compete with him? AMG510 is launched to combat KRAS gene mutation lung cancer
2025-10-19 11:44:20
Check Details
Does anyone sell ramucirumab in Sichuan? What is the price
2025-10-19 11:44:20
Check Details
How effective is Rybrevant, the blockbuster new drug for lung cancer? Where can I buy it in Chongqing?
2025-10-19 11:44:20
Check Details
How to use EGFRex20ins+ non-small cell lung cancer targeting drug Rybrevant? Are there any side effects?
2025-10-19 11:44:20
Check Details
What should I do if resistance to ramucirumab develops? What to pay attention to
2025-10-19 11:44:20
Check Details
Just now! Lung cancer targeted drug Mobotinib is on the market! How much do you know about it?
2025-10-19 11:44:20
Check Details
How much does it cost to buy EGFR-MET bispecific antibody Rybrevant in Hubei? How to use?
2025-10-19 11:44:20
Check Details
How effective is the blockbuster new drug Rybrevant? Are there any serious side effects of Rybrevant?
2025-10-19 11:44:20
Check Details
1
2
...
3968
3969
3970
3971
3972
3973
3974
...
4163
4164
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
2
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
3
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
4
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
5
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
6
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
7
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
8
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
9
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
10
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
11
Tamoxifen and Feeling Older: Managing Hot Flashes, Fatigue, and Skin Changes
12
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data